US Stock Movers
Live U.S. stock market movers ranked by gains, losses & volume with AI-powered reasons for every move.
| Name | Price | Today | Market Cap | Event Catalyst |
|---|---|---|---|---|
| $6.030 | +107.93% | 15.36M | Acurx advanced its CDI program to Phase 3 trials, showing a 96% cure rate in prior trials. | |
| $0.498 | +74.61% | 115.92M | Recent positive news catalyzed investor interest, driving SAFX's stock price up significantly. | |
| $2.280 | +65.22% | 8.09M | Positive news or announcements likely drove PAVS's +18.84% surge. | |
| $0.555 | +47.59% | 4.86M | Actelis Networks secured a $120 million contract, boosting investor confidence and driving stock price movement. | |
| $4.830 | +39.19% | 287.70M | Positive news and strong recent gains drove ROMA's stock price up by +17.29%. | |
| $1.030 | +35.35% | 6.32M | -- | |
| $9.450 | +35.00% | 213.53M | -- | |
| $10.910 | +30.97% | 78.33M | Beachbody's Q4 earnings beat expectations, contributing to the stock price increase. | |
| $2.300 | +29.94% | 754.16M | Positive news surrounding OCGN catalyzed investor interest, leading to an 18.08% stock price increase. | |
| $1.940 | +26.80% | 5.19M | Positive news and sector strength drove POLA's stock price up by 18.30%. | |
| $2.030 | +25.31% | 74.37M | CVGI's stock surged 21.91% following a notable recovery after recent declines. | |
| $10.840 | +24.88% | 2.50B | Recent positive news drove investor interest, leading to significant gains in NVTS's stock price. | |
| $0.364 | +24.16% | 332.54M | KALA's stock surged nearly 70% after announcing its AI product launch, Researgency.ai, shipping in 14 days. | |
| $2.200 | +23.60% | 1.88B | NIO's strong earnings report led to a significant surge in investor sentiment, impacting AHG's stock price. | |
| $3.550 | +21.16% | 167.32M | Positive news about ADAG boosted investor confidence, leading to a significant stock price surge. | |
| $1.910 | +20.89% | 2.69M | Fitell's rebranding to GMEX Robotics significantly boosted shares due to AI expansion plans. | |
| $0.8 | +20.65% | 212.84M | Positive news regarding PED's product launch sparked investor interest, leading to a significant stock price increase. | |
| $3.100 | +20.62% | 26.98M | Recent positive news catalyzed investor interest, driving LIXT's stock price up significantly. | |
| $5.000 | +20.48% | 482.38M | Acacia Research's Q4 earnings exceeded expectations, boosting investor confidence and stock price significantly. | |
| $22.510 | +20.37% | 647.49M | Docebo announced a $60 million share buyback, boosting investor confidence and stock value. | |
| $3.890 | +20.06% | 207.60M | -- | |
| $1.920 | +20.00% | 15.31M | Cyngn's Q1 2026 sales are expected to exceed total sales from 2025, driving stock price increase. | |
| $0.564 | +19.97% | 6.34M | Participation in the Life Sciences Virtual Investor Forum may enhance investor engagement and interest in JAGX. | |
| $3.480 | +19.59% | 231.96M | ANNA's stock surged +22.75% despite broader market declines and sector losses. | |
| $0.464 | +19.56% | 18.86M | Recent positive news significantly boosted investor sentiment for SCNX, leading to a 59.97% surge. | |
| $38.860 | +19.42% | 1.28B | Significant positive news likely boosted PZZA's stock price by +17.44%. | |
| $5.970 | +19.16% | 71.31M | Positive news-driven catalysts contributed to IXHL's significant stock price increase. | |
| $2.180 | +19.13% | 27.80M | SAGT's stock surged +25.68% despite broader market declines and sector losses. | |
| $1.150 | +18.31% | 24.83M | -- | |
| $2.260 | +17.71% | 141.11M | -- | |
| $7.130 | +17.27% | 176.23M | Artiva reported a 64% complete response rate in lymphoma trials, boosting investor interest. | |
| $3.410 | +16.78% | 39.03M | -- | |
| $5.260 | +16.63% | 297.59M | -- | |
| $2.560 | +16.36% | 29.95M | -- | |
| $111.995 | +16.14% | 28.34B | Nvidia's $2 billion investment in Nebius led to a significant stock price surge. | |
| $1.900 | +15.85% | 26.46M | -- | |
| $0.583 | +15.44% | 29.26M | -- | |
| $9.360 | +15.27% | 505.80M | -- | |
| $3.020 | +15.27% | 111.74M | -- | |
| $5.020 | +15.14% | 730.06M | -- | |
| $16.580 | +15.06% | 2.44B | SOC's stock price surged by +22.28% despite a declining broader market and many sector losers. | |
| $1.990 | +15.03% | 15.90M | -- | |
| $27.800 | +15.02% | 1.57B | Insider buying by Antal Rohit Desai boosted confidence in PRCT's future stock performance. | |
| $0.146 | +15.01% | 2.31M | Positive news and sector performance drove WORX's stock price up by +34.68%. | |
| $0.561 | +14.70% | 7.58M | -- | |
| $12.190 | +14.68% | 385.51M | -- | |
| $2.950 | +14.34% | 52.62M | -- | |
| $2.290 | +13.93% | 53.96M | Lisata Therapeutics agreed to be taken private by Kuva Labs, boosting TMDE shares significantly. | |
| $4.340 | +13.91% | 31.47M | -- | |
| $3.930 | +13.91% | 164.39M | -- |
